Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Sep 21, 2023

BUY
$74.28 - $92.69 $921,072 - $1.15 Million
12,400 Added 44.93%
40,000 $3.08 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $921,072 - $1.15 Million
12,400 Added 44.93%
40,000 $3.08 Million
Q2 2021

Aug 20, 2021

SELL
$75.51 - $84.79 $206 Million - $232 Million
-2,732,400 Reduced 99.0%
27,600 $2.3 Million
Q2 2021

Aug 16, 2021

BUY
$75.51 - $84.79 $206 Million - $232 Million
2,732,400 Added 9900.0%
2,760,000 $2.3 Million
Q1 2021

Sep 21, 2023

SELL
$74.73 - $90.69 $1.3 Million - $1.58 Million
-17,400 Reduced 38.67%
27,600 $2.08 Million
Q1 2021

May 14, 2021

SELL
$74.73 - $90.69 $1.3 Million - $1.58 Million
-17,400 Reduced 38.67%
27,600 $2.08 Million
Q4 2020

Sep 21, 2023

BUY
$72.61 - $90.2 $3.27 Million - $4.06 Million
45,000 New
45,000 $3.95 Million
Q4 2020

Feb 16, 2021

BUY
$72.61 - $90.2 $2.56 Million - $3.18 Million
35,300 Added 363.92%
45,000 $3.95 Million
Q3 2020

Nov 13, 2020

SELL
$71.87 - $131.03 $380,911 - $694,459
-5,300 Reduced 35.33%
9,700 $738,000
Q1 2020

May 15, 2020

SELL
$71.37 - $96.85 $6.1 Million - $8.28 Million
-85,500 Reduced 85.07%
15,000 $1.27 Million
Q4 2019

Feb 13, 2020

BUY
$64.27 - $86.37 $2.01 Million - $2.7 Million
31,300 Added 45.23%
100,500 $8.5 Million
Q3 2019

Nov 13, 2019

BUY
$67.4 - $85.11 $2.35 Million - $2.97 Million
34,900 Added 101.75%
69,200 $4.66 Million
Q1 2019

May 15, 2019

SELL
$84.2 - $98.62 $7.17 Million - $8.39 Million
-85,100 Reduced 71.27%
34,300 $3.05 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $8.45 Million - $11.2 Million
105,400 Added 752.86%
119,400 $10.2 Million
Q3 2018

Nov 14, 2018

BUY
$93.92 - $105.72 $957,984 - $1.08 Million
10,200 Added 268.42%
14,000 $1.36 Million
Q2 2018

Aug 14, 2018

BUY
$76.01 - $99.03 $98,813 - $128,739
1,300 Added 52.0%
3,800 $358,000
Q1 2018

May 15, 2018

BUY
$77.67 - $92.63 $194,175 - $231,575
2,500 New
2,500 $203,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.